Parabilis Medicines, Inc. (PBLS) SEC filings
PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)
Close on Nov 17, 2026Market cap $3.49BP/E –Yield –
SEC filings
9 of Parabilis Medicines's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 15, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2026 | Aug 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 11, 2026 | SEC EDGAR |
See a number that looks wrong?